Semaglutide ameliorates diabetes-associated cognitive dysfunction in mouse model of type 2 diabetes
Saved in:
| Main Authors: | Yan Zhu, Yi He, Hongyan Yang, Yanbo Gao, Yan Wang, Peiqing Liu, Mengjuan Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12225814/?tool=EBI |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
S-9-PAHSA ameliorates cognitive decline in a type 2 diabetes mouse model by inhibiting oxidative stress and apoptosis via CAIII modulation
by: Xin-Ru Wang, et al.
Published: (2025-08-01) -
Recommendations for Titration and Administration of Oral Semaglutide for the Treatment of Type 2 Diabetes during Ramadan
by: Mohamed Hassanein, et al.
Published: (2022-12-01) -
From Diabetes to Weight Loss: The Problems with Semaglutide's Expanded Use
by: Rawan Othman
Published: (2025-08-01) -
Retinal Thickness Associates with Cognition Dysfunction in Young Adult with Type 1 Diabetes in Taiwan
by: Jung-Lung Hsu, et al.
Published: (2022-01-01) -
Ameliorative Effect of Parabacteroides distaxsonis on Cognitive Impairment Caused by Type 2 Diabetes Mellitus
by: DU Yue, ZHAO Zhongna, LIU Xuebo
Published: (2025-05-01)